Skip to main content
. 2015 Sep 24;4(2):297–304. doi: 10.1177/2050640615606012

Table 3.

Differences in clinical presentation, imaging procedures and treatment among the four diagnostic subgroups of 239 patients who reported acute abdominal pain as their chief complaint at admission

Characteristics Overall (n = 239) Group NSA (n = 86) Group DIG (n = 79) Group HBP (n = 23) Group URO (n = 51) p-valuesa
Nausea/vomiting 86 (36.0%) 20 (23.3%) 40 (50.6%) 13 (56.5%) 13 (25.5%)  <0.001
Dysuria 31 (13.0%) 7 (8.1%) 2 (2.5%) 1 (4.3%) 21 (41.2%) <0.001
Heartburn/regurgitation 43 (18.0%) 11 (12.8%) 19 (24.1%) 10 (43.5%) 3 (5.9%) <0.001
Right upper quadrant pain 166 (69.5%) 58 (67.4%) 61 (77.2%) 23 (100%) 24 (47.1%) <0.001
Left upper quadrant pain 138 (57.7%) 44 (51.2%) 59 (74.7%) 14 (60.9%) 21 (41.2%) 0.001
Right lower quadrant pain 151 (63.3%) 60 (69.8%) 52 (65.8%) 6 (26.1%) 33 (64.7%) 0.001
Left lower quadrant pain 128 (53.6%) 43 (50.0%) 53 (67.1%) 2 (8.7%) 30 (58.8%) <0.001
Murphy’s sign 62 (25.9%) 18 (20.9%) 18 (22.8%) 14 (60.9%) 12 (23.5%) 0.001
Giordano’s sign 91 (38.1%) 27 (31.4%) 18 (22.8%) 5 (21.7%) 41 (80.4%) <0.001
Blumberg’s sign 156 (65.3%) 52 (60.5%) 58 (73.4%) 17 (73.9%) 29 (56.9%) 0.136
Colonic diverticula 11 (4.6%) 2 (2.3%) 9 (11.4%) 0 0 0.005
Cholelithiasis 20 (8.4%) 4 (4.7%) 7 (8.9%) 8 (34.8%) 1 (2.0%) <0.001
Abdominal X-ray 84 (35.1%) 26 (30.2%) 44 (55.7%) 8 (34.8%) 6 (11.8%) <0.001
Abdominal US 105 (43.9%) 36 (41.9%) 22 (27.8%) 13 (56.5) 34 (66.7%) <0.001
NSAIDs in ED 50 (20.9%) 9 (10.5%) 8 (10.1%) 9 (39.1%) 24 (47.1%) <0.001
Antiemetics/prokinetics in ED 47 (19.7%) 14 (16.3%) 19 (24.1%) 8 (34.8%) 6 (11.8%) 0.074
Antibiotics in ED 5 (2.1%) 0 3 (3.8%) 0 2 (3.9%) 0.232
Prescribed antibiotics 43 (18.0%) 8 (9.3%) 11 (13.9%) 1 (4.3%) 23 (45.1%) <0.001
a

NSA: non-specific abdominal pain; DIG: digestive tract-related pain; HBP: hepatopancreatic-related pain; URO: urogenital-related pain; US: ultrasound; ED: emergency department; NSAIDs: nonsteroidal anti-inflammatory drugs. Pearson chi-squared test.